Literature DB >> 10956575

Agitated symptom response to divalproex following acute brain injury.

P E Chatham Showalter1, D N Kimmel.   

Abstract

This is the largest case series (N=29) to date describing divalproex for agitation symptoms. Chart information was abstracted retrospectively for all patients who received divalproex for agitation symptoms during a 22-month period in one inpatient brain injury rehabilitation unit. For 26 patients (90%), divalproex appeared effective within 7 days after a typical 1,250 mg/day dose. Most patients (93%) were discharged to their home or community sites. Divalproex appears to be an efficacious alternative to neuroleptics and benzodiazepines for alert, labile, impulsive, and disinhibited brain injury patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956575     DOI: 10.1176/jnp.12.3.395

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  5 in total

1.  Comprehensive brain injury agitation management in the critical care setting: Preliminary results on a multidisciplinary neurobehavioral approach.

Authors:  Eugene J Rankin; Danny Jazarevic; Rona Altaras
Journal:  J Intensive Care Soc       Date:  2019-05-13

Review 2.  Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.

Authors:  Carlo Ignazio Cattaneo; Francesca Ressico; Roberta Valsesia; Pierluigi D'Innella; Matteo Ballabio; Michele Fornaro
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 3.  The use of newer anticonvulsants in neuropsychiatric disorders.

Authors:  Edward Kim
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

4.  Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review.

Authors:  David Williamson; Anne Julie Frenette; Lisa D Burry; Marc Perreault; Emmanuel Charbonney; Francois Lamontagne; Marie-Julie Potvin; Jean-Francois Giguère; Sangeeta Mehta; Francis Bernard
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

5.  Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report.

Authors:  Yasar Sattar; Saad Wasiq; Waqas Yasin; Ali M Khan; Mahwish Adnan; Shristi Shrestha; Nirav B Patel; Sharaad Latchana
Journal:  Cureus       Date:  2018-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.